Plerixafor Injection
Product Details:
- Origin of Medicine Synthetic
- Pacakaging (Quantity Per Box) 1 vial per box
- Salt Composition Plerixafor 20 mg/mL
- Drug Type Injection
- Ingredients Plerixafor
- Physical Form Liquid
- Function Used in combination with a granulocyte-colony stimulating factor to mobilize hematopoietic stem cells for collection and transplantation in patients with non-Hodgkins lymphoma and multiple myeloma.
- Click to View more
X
Plerixafor Injection Product Specifications
- Patients undergoing hematopoietic stem cell mobilization during treatment for non-Hodgkins lymphoma or multiple myeloma.
- Administered subcutaneously approximately 11 hours before apheresis. The dosage should depend on the patients body weight and under medical supervision.
- Store at 2°C to 8°C (36°F to 46°F) and protect from light.
- Available in 1.2 mL and 2 mL vial sizes.
- Plerixafor
- Injection
- Plerixafor 20 mg/mL
- Used in combination with a granulocyte-colony stimulating factor to mobilize hematopoietic stem cells for collection and transplantation in patients with non-Hodgkins lymphoma and multiple myeloma.
- Liquid
- 0.24 mg/kg body weight administered subcutaneously not exceeding 40 mg per dose.
- 1 vial per box
- Adults with non-Hodgkins lymphoma or multiple myeloma.
- Synthetic
Other Products in 'Pharmaceutical Capsules' category
Get in touch with us


